FDA
approval
· 2018-08-31
FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
FDA approved a supplemental application for CLARAVIS (isotretinoin) submitted by Teva Pharmaceuticals USA, Inc. to update the labeling.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CLARAVIS (ISOTRETINOIN)